Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients

Metabolism: Clinical and Experimental

Volumn 47, Issue 8, 1998, Pages 915-921

  Lanfredini, Mario ^b   Fiorina, Paolo ^a   Peca, Maria Grazia ^b   Veronelli, Annamaria ^b   Mello, Alessandra ^b   Astorri, Ettore ^b   Dall'Aglio, Pierpaolo ^b   Craveri, Angelo ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; COMPARTMENT MODEL; HUMAN; KINETICS; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031902326     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90344-4     Document Type: Article

References (36)

1. Sebastio G, Sperandeo MP, Panico M, et al: The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families and report of four novel mutations. Am J Hum Genet 56:1324-1333, 1995
2. Mudd S, Levy H, Skoby F: Disorders of transsulfuration, in Scriver C, Beaudet A, Sly W, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, NY, McGraw-Hill, 1995, pp 1279-1327
3. Kang S, Wong P: Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 119:135-138, 1996
4. Bostom A, Shemin D, Lapane KL, et al: Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 114:93-103, 1995
5. Tsai JC, Wang H, Perrella MA, et al: Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97:146-153, 1996
6. Lentz SR, Sobey CG, Piegors DJ, et al: Vascular dysfunction in monkeys with diet induced hyperhomocyst(e)inemia. J Clin Invest 98:24-29, 1996
7. Rodgers GM, Conn MT: Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75:895-901, 1990
8. Lentz SR, Sadler JE: Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81:683-689, 1993
9. Blom HG, Kleinveld HA, Boers GHJ, et al: Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest 25:149-154, 1995
10. Harman LS, Mottley C, Mason RP: Free radical metabolites of L-cysteine oxidation. J Biol Chem 259:5606-5611, 1984
11. Van Den Berg M, Boers GHJ, Franken DG, et al: Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25:176-181, 1995
12. Stamler JS, Osborne JA, Jaraki O, et al: Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318, 1993
13. Lentz SR, Sadler JE: Inhibition of thrombomodulin surface expression and protein C activation by thrombogenic agent homocysteine. J Clin Invest 88:1906-1914, 1991
14. Pedrinelli R, Giampietro O, Carmassi F, et al: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 334:14-18, 1994
15. WHO Study Group on Diabetes Mellitus: World Health Organ Tech Rep Ser 727:1985
16. Bostom AG, Jacques PF, Nadeau MR, et al: Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study. Atherosclerosis 116:147-151, 1995
17. Ubbink JB, Hayward Vermaak WJ, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991
18. Selhub J, Jacques PF, Wilson PWF, et al: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993
19. Rees MM, Rodgers GM: Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 71:337-339, 1993
20. Malinow MR, Kang SS, Taylor LM, et al: Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 79:1180-1188, 1989
21. Malinow MR, Ducimetiere P, Luc G, et al: Plasma homocyst(e-)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary artery disease. Atherosclerosis 126:27-34, 1996
22. Wilcken DEL, Wilcken B: The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57:1079-1082, 1976
23. Malinow MR: Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 81:2004-2006, 1990
24. Coull BM, Malinow MR, Beamer N, et al: Elevated plasma homocyst(e)ine in acute stroke and TIA: A possible independent risk factor for stroke. Stroke 21:572-576, 1990
25. Guttormsen AB, Schneede J, Fiskestrand T, et al: Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 124:1934-1941, 1994
26. Robillon JF, Canivet B, Candito M, et al: Type 1 diabetes mellitus and homocyst(e)ine. Diabete Metab 20:494-496, 1994
27. Hultberg B, Agardh E, Anderson A, et al: Increased levels of plasma homocyst(e)ine are associated with nephropathy, but not with severe retinopathy in type 1 diabetes mellitus. Scand J Clin Invest 51:277-282, 1991
28. Genest JJ, McNamara JR, Salem DN, et al: Plasma homocyst(e-)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 16:1114-1119, 1990
29. Araki A, Sako Y, Ito H: Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: Effects of parenteral methyl-cobalamin treatment. Atherosclerosis 103:149-157, 1993
30. Roos R: The pathogenesis of atherosclerosis - An update. N Engl J Med 314:488, 1986
31. Dybdahl H, Ledet T: Diabetic macroangiopathy: Quantitative histopathological studies of the extramural coronary arteries from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 30:882-886, 1987
32. Deckert T, Kofoed-Enevoldsen A, Norgaard K, et al: Microalbuminuria: Implications for micro- and macrovascular disease. Diabetes Care 15:1181-1191, 1992
33. Stehouwer CDA, Nauta JJP, Zeldenrust GC, et al: Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
34. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
35. Krolewski AS, Laffel L, Krolewski M, et al: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
36. Williams SB, Cusco JA, Roddy MA, et al: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27:567-574, 1996